Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05689333 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery
A NA study of Vitrectomy, sponsored by VISTA Ophthalmics.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 4
- Study locations
NCT05689333 is a NA study of Vitrectomy that has completed, run by VISTA Ophthalmics. The registered enrollment target is 32 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT05689333, a NA study of Vitrectomy, has completed, sponsored by VISTA Ophthalmics.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a prospective, single-arm, non-comparative, open-label, monocular, post approval study to assess safety and device performance of the Vista Vitrectomy Probe during vitrectomy surgery.
Conditions Studied
Interventions
- DEVICE Vista Vitrectomy Probe
Study Locations (4)
California
- CBCC Global Research Site:003 - Los Angeles
Florida
- CBCC Global Research Site:002 - Bradenton
Pennsylvania
- CBCC Global Research Site:001 - Bala-Cynwyd
Texas
- CBCC Global Research Site:004 - McAllen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-12-09 |
| Est. Completion | 2024-05-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05689333
The ClinicalTrials.gov registry entry for NCT05689333 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VISTA Ophthalmics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vitrectomy appearing as the primary indexed condition, and to 1 intervention - of which Vista Vitrectomy Probe is the first listed.
NCT05689333 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Florida, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05689333 about?
NCT05689333 is a clinical study titled "A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery". This is a prospective, single-arm, non-comparative, open-label, monocular, post approval study to assess safety and device performance of the Vista Vitrectomy Probe during vitrectomy surgery.
What is the current status of trial NCT05689333?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-12-09. Estimated completion is 2024-05-07.
What conditions does trial NCT05689333 study?
This clinical trial studies the following conditions: Vitrectomy.
What interventions are being tested in trial NCT05689333?
The interventions under investigation include: Vista Vitrectomy Probe (DEVICE).
Who is sponsoring clinical trial NCT05689333?
This trial is sponsored by VISTA Ophthalmics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05689333 being conducted?
This trial has 4 study locations across California, Florida, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitrectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.